AJANTPHARMAjanta Pharma Limited
Pharma · Drug Manufacturers - Specialty & Generic · NSE · as of 2026-07-19 (delayed ~30 min in market hours)
₹3,419.40
▼ 0.97%Excellent
Price & Volume
Loading chart…
Key Ratios
Market Cap (₹ cr)43,155.30
P/E40.86
P/B9.53
PEG2.20
ROE %25.39
ROCE %27.70
Debt / Equity0.06
EPS84.54
Revenue Growth %21.50
Profit Growth %18.60
Dividend Yield %0.81
Promoter Holding %54.48
FII Holding %21.68
DII Holding %—
Beta0.18
“—” means the figure isn't meaningful or isn't published for this company: ROE and Debt/Equity are undefined when shareholder equity is negative (check P/B — negative means negative equity), and DII/MF holding splits aren't provided by our current data source.
Active Pattern Signals
| Pullback to 21-EMA | LONG | 80% | ₹3,419.40 | ₹3,290.90 | ₹3,635.40 | 1.68 |
BUYConfidence 92%
- • Revenue growth: 21.5% YoY
- • Profit growth: 18.6% YoY
- • ROE: 25.4%
- • RSI: 63
- • MACD: bullish
- • Price vs EMA21: above
- • Pullback to 21-EMA signal (confidence 80%)
Bull case
- • Revenue growth: 21.5% YoY
- • Profit growth: 18.6% YoY
- • ROE: 25.4%
- • RSI: 63
Bear case
- • Volume: 0.7x 20-day average
- • Volume trend: 0.7x baseline
Key risks
- • Volume: 0.7x 20-day average
- • Volume trend: 0.7x baseline
Algorithmic analysis for research only — not SEBI-registered investment advice.
Trade Plan
Entry (CMP)
₹3,419.40
Stop Loss
₹3,159.16
risk 7.6%
Target 1 (1.5R)
₹3,809.76
+11.4%
Target 2 (3R)
₹4,200.11
+22.8%
Support (20d)
₹3,071.20
Resistance (52w)
₹3,506.90
Risk : Reward
1 : 1.5 → 1 : 3
risking ₹260.24/share
ATR (volatility)
₹104.10
avg daily range
Stop = 20-day support with a 2.5×ATR risk cap (ATR ₹104.10). Levels recompute on every data refresh. Position sizing and execution are yours — this is analysis, not advice.
Score Breakdown
Fundamental
81
Technical
78
Momentum
87
Risk (safety)
78